Naperville, IL -- (SBWIRE) -- 10/09/2012 -- Aduro BioTech - Product Pipeline Review - 2012 provides data on the Aduro BioTech’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.
This report is built using data and information sourced from Global Markets Direct’s proprietary databases, Aduro BioTech’s corporate website, SEC filings, investor presentations and featured press releases, both from Aduro BioTech and industry-specific third party sources, put together by Global Markets Direct’s team.
- Aduro BioTech - Brief Aduro BioTech overview including business description, key information and facts, and its locations and subsidiaries.
- Review of current pipeline of Aduro BioTech human therapeutic division.
- Overview of pipeline therapeutics across various therapy areas.
- Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe.
- Product profiles for late stage and clinical stage products of Aduro BioTech with complete description of the product’s developmental history, mechanism of action, therapeutic class, target and major milestones.
- Recent updates of the Aduro BioTech’s pipeline in the last quarter.
- Key discontinued and dormant projects.
- Latest news and deals relating to the products.
Reasons to buy
- Evaluate Aduro BioTech’s strategic position with total access to detailed information on its product pipeline.
- Assess the growth potential of Aduro BioTech in its therapy areas of focus.
- Identify new drug targets and therapeutic classes in the Aduro BioTech’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas.
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps.
- Exploit collaboration and partnership opportunities with Aduro BioTech.
- Avoid Intellectual Property Rights related issues.
- Explore the dormant and discontinued projects of Aduro BioTech and identify potential opportunities in those areas.
Current R&D Portfolio of Aduro BioTech; Aduro BioTech - Key Therapeutics; Aduro BioTech - Pipeline Overview and Promising Molecules; Aduro BioTech - News; Aduro BioTech - Latest Updates; Aduro BioTech - Pipeline; Aduro BioTech - Discontinued/Dormant Projects
To view table of contents for this market report please visit: